Medication info

Gliduocure Tablet 10/100 mg

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletSitagliptin Phosphate Hydrate›128.5mg / 1 tablet
Manufacturer / importer
Seongyi Bio Pharmaceutical Co., Ltd.
Appearance
Bright yellow, rectangular film-coated tablet
Packaging
Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)]
Approval status
Active

MFDS item code 202200215 · Approved 2022.01.12

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate(eGFR) is less than 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Seongyi Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is prescribed in conjunction with dietary changes and exercise programs to assist in blood glucose control for patients with type 2 diabetes using sitagliptin and dapagliflozin together. It is used to effectively manage blood glucose levels and improve symptoms of diabetes.

Dosage and Administration

Adult dosage

This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - Do not administer this medicine when the estimated glomerular filtration rate(eGFR) is less than 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Precautions

This medication contains sitagliptin and dapagliflozin and is used for the treatment of diabetes. Firstly, sitagliptin may rarely cause serious allergic reactions such as anaphylaxis, angioedema, or skin exfoliative diseases, so if any abnormal symptoms occur within 3 months after administration, it should be discontinued immediately. Additionally, sitagliptin may induce acute pancreatitis, thus if symptoms like abdominal pain or vomiting occur during treatment, it is essential to consult medical personnel immediately. This medication should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Dapagliflozin poses a risk of volume depletion and renal dysfunction, thus patients with impaired kidney function, elderly patients, or those on diuretics should evaluate their fluid status and renal function adequately before administration and be monitored regularly during treatment. This medication may lead to metabolic abnormalities, including severe pancreatitis and diabetic ketoacidosis, so if such symptoms are suspected, immediate discontinuation and treatment should be sought. Furthermore, dapagliflozin may increase the risk of genital and urinary tract infections, so appropriate treatment is necessary if infection symptoms develop. Elderly patients are at higher risk of decreased kidney function, so dose adjustment and renal function tests are recommended. Pregnant or breastfeeding women are advised to avoid using this medication, and it should be discontinued immediately if pregnancy is confirmed. While taking this medication, there is a risk of hypoglycemia, especially when used in conjunction with insulin or sulfonylureas, thus caution is necessary for hypoglycemic symptoms, and dosage adjustments may be required. In cases of overdose, appropriate treatment should be sought according to the symptoms, and while some drug components may be removed by dialysis, specific treatment methods should be discussed with medical personnel. Lastly, this medication has not established safety and efficacy in children, so it should not be used in patients under 18 years of age. There is a risk of hypoglycemia when driving or operating machinery during the use of this medication, so caution is warranted.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • genital infections
  • vulvovaginitis
  • balanitis
Show 150 more
  • urinary tract infections
  • fungal infections
  • perineal necrosis
  • hypoglycemia
  • reduced fluid volume
  • thirst
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • elevated serum creatinine
  • dyslipidemia
  • rash
  • urticaria
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcers
  • abnormal sweating dermatitis
  • nummular eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • headache
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • abdominal pain
  • gastritis
  • gastrointestinal disorders
  • abdominal discomfort
  • decreased appetite
  • thirst
  • vaginal discharge
  • menstrual irregularities
  • pruritus
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprains
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • tinnitus
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • asthenia
  • pain
  • edema
  • fever
  • facial edema
  • facial pain
  • warmth
  • influenza-like symptoms
  • breast mass
  • erectile dysfunction
  • benign prostatic hyperplasia
  • breast pain
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • vulvar discomfort
  • hair loss
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteoporosis
  • contusion
  • drug toxicity
  • ankle fracture
  • hand fracture
  • iliac fracture
  • thoracic vertebra fracture
  • tibia fracture
  • dental injury
  • dry eye
  • eye pain
  • retinal disorders
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • double vision
  • eyelid edema
  • keratitis
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • speech disorders
  • epistaxis
  • hemoptysis
  • sputum
  • sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • cerebral hemorrhage
  • flushing
  • peripheral artery occlusion
  • peripheral cooling
  • varicose veins
  • vascular headaches
  • angina
  • atrial fibrillation
  • diastolic dysfunction
  • myocardial infarction
  • anxiety disorders
  • nocturnal enuresis
  • hallucinations
  • sleep disorders
  • suicide attempts
  • fatty liver
  • gallbladder polyps
  • dizziness
  • gastric adenocarcinoma
  • anal genital warts
  • gastric adenoma
  • neuroma
  • unspecified pituitary neoplasm
  • male reproductive gland hypofunction
  • thyroid cysts
  • thyroid nodules
  • anaphylactic reaction
  • food allergies
  • erythrocytosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect against air and moisture and should be kept at room temperature, ideally between 1 to 30 degrees Celsius. Avoid storing in warm or excessively cold places and keep it in a cool place away from direct sunlight.

Appearance and packaging

Appearance

Bright yellow, rectangular film-coated tablet

Package unit

Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.